Form D · Pharmaceuticals
iTherx Pharma, Inc.
San Diego, CA · CIK 0001531965
Offering snapshot reported Nov 4, 2011 · SEC filing
- Reported sold
- $3.17M Offering amount: $3.17M
- Investors reported
- 19 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Sep 8, 2011 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 4, 2011 | Initial | $3,173,595 | No comparison | 19 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-168269
Source: Form D, filed Nov 4, 2011. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Franklin Berger | Director |
| John H. Friedman | Director, Executive |
| Steven B. Gerber, M.D. | Director |
| Amanda Iles | Executive |
| Frank Litvack, M.D. | Director |
| Jeffrey F. Mc Kelvy, Ph.D. | Director, Executive |
| Eve Slater | Director |
| Flossie Wong Staal, Ph.D. | Director, Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
14090 Caminito Vistana
San Diego, CA, 92130
San Diego, CA, 92130